share_log

Nanobiotix S.A. (NASDAQ:NBTX) Sees Significant Increase in Short Interest

Nanobiotix S.A. (NASDAQ:NBTX) Sees Significant Increase in Short Interest

Nanobiotix S.A.(纳斯达克市场代码:NBTX)的空头股数业务大幅增长
Financial News Live ·  2022/09/30 13:32

Nanobiotix S.A. (NASDAQ:NBTX – Get Rating) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 9,100 shares, a growth of 116.7% from the August 31st total of 4,200 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,600 shares, the days-to-cover ratio is currently 3.5 days.

纳斯达克:NBTX-GET评级公司(Nanobiotix S.A.)在9月份见证了空头股数的大幅增长。截至9月15日,空头股数共有9,100股,较8月31日的4,200股增长116.7%。目前,该股有0.0%的股份被卖空。以日均成交量2,600股计算,目前天数与回补比率为3.5天。

Nanobiotix Stock Performance

Nanobiotix股票表现

Shares of NBTX traded up $0.02 during mid-day trading on Friday, hitting $3.48. The company's stock had a trading volume of 940 shares, compared to its average volume of 1,229. The firm has a 50-day moving average price of $3.99 and a 200 day moving average price of $4.88. Nanobiotix has a fifty-two week low of $2.32 and a fifty-two week high of $13.37.

在周五午盘交易中,NBTX的股价上涨了0.02美元,达到3.48美元。该公司股票的总成交量为940股,而其平均成交量为1229股。该公司的50日移动均线价格为3.99美元,200日移动均线价格为4.88美元。Nanobiotix的52周低点为2.32美元,52周高位为13.37美元。

Get
到达
Nanobiotix
纳米生物
alerts:
警报:

Nanobiotix Company Profile

Nanobiotix公司简介

(Get Rating)

(获取评级)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Nanobiotix SA是一种临床阶段的生物技术,专注于开发治疗癌症的候选产品。它的主要候选产品是NBTXR3,这是一种由晶态氧化钨纳米颗粒组成的无菌水悬浮液,用于治疗软组织肉瘤、头颈癌、肝癌、前列腺癌、胰腺癌、食道癌、直肠癌和非小细胞肺癌。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Nanobiotix (NBTX)
  • This Is A Memorable Time To Buy Into Micron Technology
  • Let Paychex Stock Work Hard For You
  • Thor Industries Hammers Out A Bottom
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • Declining Profits Challenge the CarMax Value Proposition
  • 免费获取StockNews.com关于Nanobiotix的研究报告(NBTX)
  • 这是买入美光科技的难忘时刻
  • 让Paychex股票为您努力工作
  • 雷神工业走出谷底
  • Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?
  • 利润下降对CarMax价值主张的挑战

Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.

接受Nanobiotix日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Nanobiotix和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发